Dashboard
LoginSign Up

Financial News

Indian university presents Chinese robot as its own at AI summit
geo123d ago

Indian university presents Chinese robot as its own at AI summit

A woman shakes hand with robotic dog presented by Galgotias University. X@GalgotiasGUNEW DELHI: An Indian university has been asked to vacate its stall at the country's flagship AI summit after a staff member was caught presenting a commercially available robotic dog made in...

#TECH
Can a CRISPR blood test spot cancer early? #science
biztoc123d ago

Can a CRISPR blood test spot cancer early? #science

A light based CRISPR sensor aims for earlier detection Researchers have combined CRISPR molecular recognition with an ultrasensitive light readout to build a blood test that can detect minute molecular signs of cancer in a single drop of blood. The platform uses the sequence specific targeting of...

#TECH
NewBiologix Announces Publication of Breakthrough HEK293 Cell Line Optimized for High-Quality rAAV Production
manilatimes123d ago

NewBiologix Announces Publication of Breakthrough HEK293 Cell Line Optimized for High-Quality rAAV Production

Paper reports two-fold higher full-to-empty rAAV ratio using NBX1P01 compared to a leading commercial HEK293 cell lineLAUSANNE, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NewBiologix S.A., a biotechnology company advancing recombinant adeno-associated virus (rAAV) production through next-generation clonal HEK293 cell line technology, today announced publication of peer-reviewed data in Biotechnology Reports (Vol. 49, March 2026).The paper (1), authored by NewBiologix, covers the generation and characterization of NBX1P01, the company’s proprietary clonal HEK293 cell line optimized for rAAV production. Derived from more than 2,000 single-cell clones, NBX1P01 was selected for enhanced production performance and validated through extensive genomic sequencing to confirm clonality and stability. This clonal cell line underpins rapid, effective, and scalable production of viral vectors central to gene therapy manufacturing.After comprehensive evaluation, the publication reports the following key findings:Full-to-empty capsid ratio: In head-to-head studies using identical protocols, NBX1P01 demonstrated a two-fold higher full-to-empty rAAV capsid ratio compared to a leading commercial HEK293 cell line. Full capsid content is a critical product quality attribute in rAAV manufacturing.Genomic stability: The clone remained genomically stable over 55 population doubling levels and exhibited lower genetic heterogeneity than the parental HEK293 population.Genome integrity: Long-read sequencing confirmed more than 70% intact rAAV genomes with minimal encapsidated contaminating DNA.Scalability and versatility: NBX1P01 demonstrated consistent performance across production volumes ranging from 10 mL to 1.5 L and supported multiple rAAV serotypes and clinically relevant transgene sizes. Igor Fisch, CEO and Co-founder of NewBiologix, said, "As the gene therapy landscape evolves, manufacturing platforms must radically improve in performance. Our goal is to help revolutionize gene therapy by ushering in a more reliable and consistent industrial scale manufacturing foundation. This peer-reviewed publication validates our precision-built, high performance, stable HEK293 platform and showcases its reliability and consistency for quality rAAV production.”Efrain Guzman, VP, Innovation & Business Development at NewBiologix, said, "We’re determined to make gene therapies more accessible and provide safe and effective therapies to patients. In viral vector manufacturing, quality is essential to assure the product’s integrity from day one. Choosing a reliable, stable and adaptable cell line that demonstrates consistent performance is foundational to achieving that goal.”Manufacturing scalability and product quality remain central challenges in rAAV-based gene therapy development, particularly as programs expand beyond rare diseases into broader patient populations. Improvements in cell line stability impact product quality and dramatically reduce variability, thereby increasing manufacturing efficiency and enhancing overall product consistency.For additional technical information, see the company’s latest Scientific White Paper (2).References(1) Generation and characterization of a HEK293 cell line optimized for recombinant adeno-associated virus production:https://doi.org/10.1016/j.btre.2026.e00948(2) Unlocking Scalable, High-Quality rAAV Production with XcellTM Eng-HEK293: https://145175225.hs-sites-eu1.com/white-paper-hek293About NewBiologix S.A.NewBiologix is a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through its proprietary, high performance, stable HEK293 platform technology. Headquartered in Lausanne, Switzerland, and backed by a world-class scientific team and leading investors, the company focuses on addressing one of the most critical bottlenecks in gene therapy: reproducible, cost-efficient, and high-quality vector manufacturing. By integrating its proprietary HEK293-based cell lines with its suite of advanced production tools, NewBiologix supports partners from research through commercialization to enable more consistent and reliable gene therapy manufacturing.Visit our website and follow us on LinkedIn.Media contactsNewBiologixIgor Fisch, CEOcontact@newbiologix.comScius Communications (for NewBiologix)Katja Stout, katja@sciuscommunications.com+44 7789 435990Daniel Gooch, daniel@sciuscommunications.com+44 7747 875479

#TECH
Australia Set Global Engagement on AI, Promote Plan At India AI Impact Summit 2026
newsblare123d ago

Australia Set Global Engagement on AI, Promote Plan At India AI Impact Summit 2026

Australia is increasing its involvement in global discussions about artificial intelligence. This week, Assistant Minister for Science, Technology and the Digital Economy Dr. Andrew Charlton visiting India to take part in the AI Impact Summit. This event is one of the leading forums for AI policy and governance worldwide. Australia promote Plan at India AI [...]The post Australia Set Global Engagement on AI, Promote Plan At India AI Impact Summit 2026 appeared first on Newsblare.

#TECH
Trump Organization seeks trademark for airports bearing president’s name
mid_day123d ago

Trump Organization seeks trademark for airports bearing president’s name

The Trump Organization has filed trademark applications to secure exclusive rights to use President Donald Trump’s name for airports and related services, amid debate over renaming facilities in Florida and elsewhere. The applications, submitted by a company unit called DTTM Operations to the US Patent and Trademark Office, seek control over names

#TECH